Phase 2 Chronic kidney disease trials recruiting now

All Chronic kidney disease trials, every phase

Other phases for Chronic kidney disease

Phase 2 Chronic kidney disease trials

• A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
  NCT06310967 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
  NCT07496177 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · 79 locations
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
  NCT07222917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 71 locations
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 147 locations
• A Study of Luspatercept in People With Anemia
  NCT07725497 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
  NCT07268638 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 25 locations
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 44 locations
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
  NCT06712654 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 31 locations
• A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
  NCT07231679 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
  NCT06942910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
  NCT06721143 · Phase: Phase 1, Phase 2 · Ages: 35 Years to 75 Years · Sex: All (male and female) · 2 locations
• Activated Charcoal Use in Chronic Kidney Disease Patients
  NCT06906874 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Acute Equol Supplementation and Vascular Function in Women With and Without CKD
  NCT06128278 · Phase: Phase 2 · Ages: 50 Years to 69 Years · Sex: Female · 1 location
• Adding Urea to the Final Dialysis Fluid
  NCT06366230 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
  NCT07072468 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
  NCT04500665 · Phase: Phase 2 · Ages: 21 Years to 80 Years · Sex: All (male and female) · 1 location
• Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease
  NCT06923709 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Breakthrough - T1DM and Chronic Kidney Disease
  NCT07592000 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
  NCT07053462 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 85 Years · Sex: All (male and female) · 1 location
• Canagliflozin in Advanced Renal Disease With MRI Endpoints
  NCT06182839 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
  NCT06929169 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1114 locations
• Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
  NCT07304817 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
  NCT05325099 · Phase: Phase 1, Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Effect Camostat for Kidney Protection in Chronic Kidney Disease
  NCT06794593 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
  NCT06913647 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD
  NCT05359263 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Equol and Vascular Function in Women With Chronic Kidney Disease
  NCT07194590 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · 1 location
• Ertugliflozin in Chronic Heart Failure
  NCT04438213 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Ferric Citrate and Chronic Kidney Disease in Children
  NCT04741646 · Phase: Phase 2 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 20 locations
• Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
  NCT05753930 · Phase: Phase 2 · Ages: 1 Year to 17 Years · Sex: All (male and female) · 6 locations
• Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
  NCT07607197 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
  NCT06897605 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
  NCT03321656 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Improving Coronary Vascular Health in Women
  NCT06843902 · Phase: Phase 2 · Ages: 45 Years to 75 Years · Sex: Female · 1 location
• Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.
  NCT07666815 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lumasiran in Hyperoxalaemic Patients on Haemodialysis
  NCT06225544 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
  NCT05928936 · Phase: Phase 2 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 2 locations
• Neurovascular Transduction During Exercise in Chronic Kidney Disease
  NCT02947750 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
  NCT07494045 · Phase: Phase 2 · Ages: 1 Month to 17 Years · Sex: All (male and female) · 5 locations
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
  NCT06434363 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
  NCT04180085 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial
  NCT06863194 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• REgulatory T Cell Therapy to Achieve Immunosuppression REduction
  NCT06552169 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 7 locations
• Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
  NCT06917950 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
  NCT06903559 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
  NCT06155604 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
  NCT04580420 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 18 locations
• Safety and Efficacy of Empagliflozin in Hemodialysis
  NCT05786443 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
  NCT06593392 · Phase: Phase 2 · Ages: 12 Years to 18 Years · Sex: All (male and female) · 17 locations
• Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
  NCT05027906 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 9 locations
• Sit Less, Interact and Move More (SLIMM) 2 Study
  NCT05173714 · Phase: Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 4 locations
• Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
  NCT04984226 · Phase: Phase 2 · Ages: 21 Years to 85 Years · Sex: All (male and female) · 2 locations
• Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis
  NCT06976177 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
  NCT05287945 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 58 locations
• Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
  NCT06878560 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 2 locations
• Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
  NCT07224763 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location
• Swedish Cardiac And Renal Failure Study-1
  NCT07029503 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Testosterone Treatment in Men With Chronic Kidney Disease
  NCT05249634 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi
  NCT06836206 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• UBT251 Injection Phase II Clinical Study (CKD)
  NCT07134335 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.